TOC - Global Targeted Sequencing Market

1
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
res
Focus on Product Type, Target Enrichment
Method, Type of Target Capture,
Application, End User, and Region
Analysis
Analysis and Forecast: 2022-2032
January 2023
Targeted
Sequencing
Market –
A Global and
Regional Analysis
Table of Content

2
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-
depth market intelligence reports focusing on market estimations, technology analysis, emerging high-growth
applications, deeply segmented granular country-level market data, and other important market parameters
useful in the strategic decision-making for senior management. BIS Research provides multi-client reports,
company profiles, databases, and custom research services.
Copyright © 2023 BIS Research Inc.
All Rights Reserved. This document contains highly confidential information and is the sole property of BIS
Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this
document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people
or organization concerned. It may not be accessed by or offered, whether for sale or otherwise, to any third
party.

3
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Table of Content
Executive Summary..........................................................................26
1. Markets .....................................................................................34
1.1 Inclusion and Exclusion Criteria ....................................................................35
1.2 Market Scope ...................................................................................................35
1.2.1 Scope of the Study............................................................................................ 35
1.2.2 Key Questions Answered in the Report.......................................................... 36
1.3 Research Methodology ...................................................................................37
1.3.1 Global Targeted Sequencing Market: Research Methodology ..................... 37
1.3.2 Data Sources ..................................................................................................... 37
1.3.2.1 Primary Data Sources ................................................................................... 37
1.3.2.2 Secondary Data Sources .............................................................................. 38
1.3.3 Market Estimation Model.................................................................................. 38
1.3.4 Criteria for Company Profiling......................................................................... 40
2. Market Overview........................................................................41
2.1 Market Overview ..............................................................................................42
2.1.1 Market Definition ............................................................................................... 42
2.1.2 Market Footprint and Growth Potential........................................................... 42
2.1.3 Future Potential................................................................................................. 43
2.1.4 Comparison of Whole Genome Sequencing, Whole Exome
Sequencing, and Targeted Sequencing Methods .......................................... 45
2.1.5 Evolution of Targeted Sequencing (Sanger Sequencing vs. NGS) .............. 46
2.1.5.1 First-Generation Sequencing ........................................................................ 47
2.1.5.2 Second-Generation Sequencing (Next-Generation Sequencing) ................. 47
2.1.5.3 Third-Generation Sequencing ....................................................................... 48
2.1.6 COVID-19 Impact on Targeted Sequencing Market........................................ 48
2.1.6.1 Impact on Research and Clinical Operations ................................................ 49
2.1.6.2 COVID-19 Impact: Current Scenario of the Market....................................... 49
3. Industry Analysis ......................................................................50
3.1 Legal Requirements ........................................................................................51

4
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
3.1.1 Legal Requirements and Framework in the U.S............................................. 51
3.1.2 U.S. FDA Published Guidance ......................................................................... 51
3.1.3 U.S. FDA Regulations ....................................................................................... 52
3.1.4 Legal Requirements Framework in Europe .................................................... 52
3.1.5 Legal Requirements and Framework in Asia-Pacific..................................... 53
3.1.5.1 China............................................................................................................. 53
3.1.5.2 Japan............................................................................................................. 53
3.1.5.2.1 Pharmaceuticals and Medical Devices Agency (PMDA) ......................................... 53
3.1.5.2.2 Ministry of Health, Labour and Welfare (MHLW)..................................................... 53
3.1.5.3 India............................................................................................................... 54
3.2 Patent Analysis................................................................................................54
3.2.1 Patent Filing Trend............................................................................................ 54
3.2.2 Patent Analysis (by Year) ................................................................................. 54
3.2.3 Patent Analysis (by Country) ........................................................................... 55
3.2.4 Patent Analysis (by Region)............................................................................. 56
4. Market Dynamics .......................................................................57
4.1 Overview...........................................................................................................58
4.2 Impact Analysis ...............................................................................................58
4.3 Market Drivers..................................................................................................60
4.3.1 Rising Need for Sequencing at Greater Depth ............................................... 60
4.3.2 Lower Cost and Data Burden of Targeted Sequencing When Compared
to Whole Genome Sequencing ........................................................................ 61
4.3.3 Increase in Cancer Prevalence ........................................................................ 61
4.4 Market Challenges...........................................................................................62
4.4.1 Lack of Knowledge About New Genes and Biomarkers................................ 62
4.4.2 Lack of High Complexity Genomic Testing Centers in High Potential
Markets............................................................................................................... 63
4.5 Market Opportunities.......................................................................................63
4.5.1 Increasing Use in Clinical Research and Trials for Better Disease
Pathogenesis and/or Clinical Relevance ........................................................ 63

5
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
4.5.2 Rising Adoption of Targeted Sequencing in Targeted Therapeutics........... 64
5. Competitive Landscape .............................................................65
5.1 Overview...........................................................................................................66
5.2 Corporate Strategies .......................................................................................66
5.2.1 Mergers and Acquisitions ................................................................................ 66
5.2.2 Synergistic Activities........................................................................................ 68
5.3 Business Strategies ........................................................................................69
5.3.1 Product Launches/Upgradations..................................................................... 69
5.3.2 Business Expansion and Funding .................................................................. 71
5.4 Supply Chain Analysis ....................................................................................72
5.4.1 Key Entities in Supply Chain ........................................................................... 72
5.5 Market Share Analysis (by Company)............................................................73
5.6 Growth Share Analysis ...................................................................................74
5.6.1 Growth Share Analysis (by Application)......................................................... 74
5.6.2 Growth Share Analysis (by End User)............................................................. 76
6. Global Targeted Sequencing Market (by Product Type),
($Million), 2021-2032..................................................................77
6.1 Overview...........................................................................................................78
6.2 Services............................................................................................................80
6.3 Kits/Panels and Assays ..................................................................................81
6.4 Instruments ......................................................................................................83
6.5 Other Product Types .......................................................................................84
7. Global Targeted Sequencing Market (By Target Enrichment
Method), ($Million), 2021-2032 ...................................................86
7.1 Overview...........................................................................................................87
7.2 Amplicon Sequencing .....................................................................................89
7.3 Hybridization Capture .....................................................................................90
7.4 Other Target Enrichment Methods.................................................................91
8. Global Targeted Sequencing Market (by Type of Target
Capture), $Million, 2021-2032 ....................................................93

6
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
8.1 Overview...........................................................................................................94
8.2 Targeted DNA Sequencing..............................................................................95
8.2.1 Targeted Methyl Sequencing ........................................................................... 96
8.3 Targeted RNA Sequencing..............................................................................97
8.3.1 Targeted Metagenomic Sequencing................................................................ 98
8.4 Other Types of Target Capture.......................................................................99
9. Global Targeted Sequencing Markets (by Application),
$Million, 2021-2032..................................................................100
9.1 Overview.........................................................................................................101
9.2 Oncology ........................................................................................................103
9.2.1 Solid Tumor ..................................................................................................... 104
9.2.2 Liquid Biopsy .................................................................................................. 105
9.2.3 Minimal Residual Disease Testing ................................................................ 105
9.2.4 Circulating Tumor Cell (CTC) Analysis ......................................................... 106
9.3 Infectious Diseases .......................................................................................106
9.4 Cardiovascular Diseases ..............................................................................108
9.5 Reproductive Health......................................................................................109
9.5.1 Carrier Screening ............................................................................................ 110
9.5.2 Non-Invasive Prenatal Testing....................................................................... 110
9.5.3 Preimplantation Genetic Diagnosis (PGD).................................................... 111
9.5.4 Newborn Screening ........................................................................................ 112
9.6 Rare Diseases ................................................................................................112
9.7 Neurological Disorders .................................................................................113
9.8 Hereditary Diseases ......................................................................................114
9.9 Other Applications.........................................................................................115
10. Global Targeted Sequencing Market (By End User), ($Million),
2021-2032................................................................................117
10.1 Overview.........................................................................................................118
10.1.1 Academic and Research Institutions ............................................................ 119
10.1.2 Pharmaceutical and Biotech Companies...................................................... 120

7
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
10.1.3 Diagnostic and Clinical Laboratories............................................................ 121
10.1.4 Other End Users.............................................................................................. 122
11. Global Targeted Sequencing Market, by Region, $Million,
2021-2032................................................................................124
11.1 Overview.........................................................................................................125
11.2 North America................................................................................................128
11.2.1 U.S. ................................................................................................................... 130
11.2.2 Canada ............................................................................................................. 131
11.3 Europe ............................................................................................................134
11.3.1 Germany........................................................................................................... 136
11.3.2 France .............................................................................................................. 137
11.3.3 U.K.................................................................................................................... 138
11.3.4 Italy................................................................................................................... 139
11.3.5 Spain ................................................................................................................ 140
11.3.6 Rest-of-Europe ................................................................................................ 141
11.4 Asia-Pacific ....................................................................................................143
11.4.1 China ................................................................................................................ 145
11.4.2 Japan................................................................................................................ 146
11.4.3 India.................................................................................................................. 147
11.4.4 Australia........................................................................................................... 147
11.4.5 South Korea..................................................................................................... 148
11.4.6 Rest-of-Asia-Pacific ........................................................................................ 149
11.5 Latin America.................................................................................................150
11.5.1 Brazil ................................................................................................................ 152
11.5.2 Mexico.............................................................................................................. 153
11.5.3 Rest-of-Latin America..................................................................................... 154
11.6 Rest-of-the-World (RoW)...............................................................................155
12. Company Profiles.....................................................................156
12.1 Overview.........................................................................................................157
12.2 Market Value Chain of Targeted Sequencing Market .................................158

8
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
12.3 Agilent Technologies, Inc. ............................................................................159
12.3.1 Company Overview......................................................................................... 159
12.3.2 Role of Agilent Technologies, Inc. in the Global Targeted Sequencing
Market............................................................................................................... 159
12.3.3 Key Customers of the Company.................................................................... 160
12.3.4 Key Competitors of the Company ................................................................. 161
12.3.5 Financials......................................................................................................... 161
12.3.6 Key Insights about the Financial Health of the Company........................... 163
12.3.7 Corporate Strategies....................................................................................... 163
12.3.7.1 Synergistic Activities.................................................................................... 163
12.3.8 Business Strategies........................................................................................ 164
12.3.8.1 Business Expansion and Funding............................................................... 164
12.3.9 Analyst Perspective ........................................................................................ 164
12.4 Azenta US, Inc. (GENEWIZ)...........................................................................165
12.4.2 Role of Azenta US, Inc. in the Global Targeted Sequencing Market .......... 165
12.4.5 Financials......................................................................................................... 167
12.4.8.1 Business Expansion and Funding............................................................... 169
12.5 BGI Group (MGI Tech Co., Ltd.)....................................................................171
12.5.2 Role of BGI Group in the Global Targeted Sequencing Market.................. 171

9
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
12.6 CD Genomics .................................................................................................173
12.6.2 Role of CD Genomics in the Global Targeted Sequencing Market............. 173
12.6.4.1 Product Launches and Upgradations.......................................................... 174
12.7 Daicel Corporation (Daicel Arbor Biosciences) ..........................................176
12.7.2 Role of Daicel Corporation (Daicel Arbor Biosciences) in the Global
Targeted Sequencing Market ......................................................................... 176
12.7.5 Financials......................................................................................................... 178
12.7.7.1 Mergers and Acquisitions............................................................................ 180
12.8 Danaher. (Integrated DNA Technologies, Inc.)............................................182
12.8.2 Role of Danaher. in the Global Targeted Sequencing Market..................... 182
12.8.5 Financials......................................................................................................... 184

10
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
12.8.8.1 Product Launch/ Approval........................................................................... 187
12.8.8.2 Funding and Expansion............................................................................... 187
12.9 F. Hoffmann-La Roche Ltd............................................................................189
12.9.2 Role of F. Hoffmann-La Roche Ltd in the Global Targeted Sequencing
Market............................................................................................................... 189
12.9.4 Financials......................................................................................................... 191
12.10 Illumina, Inc....................................................................................................195
12.10.2 Role of Illumina, Inc. in the Global Targeted Sequencing Market .............. 195
12.10.4 Financials......................................................................................................... 197
12.11 LGC Limited (LGC Biosearch Technologies) ..............................................201

11
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
12.11.2 Role of LGC Limited (LGC Biosearch Technologies) in the Global
Targeted Sequencing Market ......................................................................... 201
12.11.4 Financials......................................................................................................... 203
12.12 PacBio. ...........................................................................................................206
12.12.2 Role of PacBio. in the Global Targeted Sequencing Market....................... 206
12.12.5 Financials......................................................................................................... 208
12.13 PerkinElmer Inc..............................................................................................212
12.13.2 Role of PerkinElmer Inc. in the Global Targeted Sequencing Market........ 212
12.13.5 Financials......................................................................................................... 214

12
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
12.14 Psomagen.......................................................................................................218
12.14.2 Role of Psomagen in the Global Targeted Sequencing Market.................. 218
12.14.5 Financials......................................................................................................... 220
12.15 QIAGEN N.V....................................................................................................222
12.15.2 Role of QIAGEN N.V. in the Global Targeted Sequencing Market.............. 222
12.15.5 Financials......................................................................................................... 224
12.16 Takara Bio Inc. ...............................................................................................228
12.16.2 Role of Takara Bio Inc. in the Global Targeted Sequencing Market........... 228

13
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
12.16.5 Financials......................................................................................................... 230
12.17 Tecan Trading AG..........................................................................................233
12.17.2 Role of Tecan Trading AG in the Global Targeted Sequencing Market ..... 233
12.17.5 Financials......................................................................................................... 235
12.18 Thermo Fisher Scientific Inc.........................................................................238
12.18.2 Role of Thermo Fisher Scientific Inc. in the Global Targeted
Sequencing Market ......................................................................................... 238
12.18.5 Financials......................................................................................................... 240

14
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
12.19 Twist Bioscience............................................................................................245
12.19.2 Role of Twist Bioscience. in the Global Targeted Sequencing Market...... 245
12.19.5 Financials......................................................................................................... 247
12.20 Emerging Companies....................................................................................251
12.20.1 MedGenome..................................................................................................... 251
12.20.2 Novogene Co, Ltd. .......................................................................................... 251
12.20.3 Paragon Genomics, Inc. ................................................................................. 252
12.20.4 Sage Science, Inc............................................................................................ 252
12.20.5 Zymo Research Corporation.......................................................................... 253

15
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
List of Figures
Figure 1: Global Targeted Sequencing Market, $Million, 2021 and 2032
Figure 2: Global Targeted Sequencing Market Segmentation
Figure 3: Global Targeted Sequencing Market (by Product Type), $Million, 2021-2032
Figure 4: Global Targeted Sequencing Market (by Target Enrichment Method), $Million, 2021-2032
Figure 5: Global Targeted Sequencing Market (by Type of Target Capture), $Million, 2021-2032
Figure 6: Global Targeted Sequencing Market (by Application), $Million, 2021-2032
Figure 7: Global Targeted Sequencing Market (by End User), $Million, 2021-2032
Figure 8: Global Targeted Sequencing Market (by Region)
Figure 9: Global Targeted Sequencing Market Segmentation
Figure 10: Global Targeted Sequencing Market: Research Methodology
Figure 11: Primary Research Methodology
Figure 12: Bottom-Up Approach (Segment-Wise Analysis)
Figure 13: Top-Down Approach (Segment-Wise Analysis)
Figure 14: Comparison between Whole Genome Sequencing, Whole Exome Sequencing, and Targeted
Sequencing Methods
Figure 15: Whole Genome Sequencing
Figure 16: Whole Exome Sequencing
Figure 17: Targeted Sequencing
Figure 18: Evolution of Targeted Sequencing Over the Three Generations
Figure 19: FDA’s Regulatory Insight System
Figure 20: Global Targeted Sequencing Market, Patent Analysis (by Year), January 2020-December 2022
Figure 21: Global Targeted Sequencing Market, Patent Analysis (by Country), January 2020-December
2022
Figure 22: Global Targeted Sequencing Market, Patent Analysis (by Region), January 2020-December
2022
Figure 23: Global Targeted Sequencing Market Dynamics
Figure 24: Global Cancer Deaths between 2010-2019
Figure 25: Share of Key Developments, January 2020-December 2022
Figure 26: Share of Mergers and Acquisitions (by Company), January 2019-December 2022
Figure 27: Share of Synergistic Activities (by Company), January 2019-December 2022
Figure 28: Share of Product Launches/Upgradations (by Company), January 2019-December 2022

16
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Figure 29: Share of Business Expansion and Funding Activities (by Company), January 2019-December
2022
Figure 30: Targeted Sequencing Supply Chain Analysis
Figure 31: Market Share Analysis of Global Targeted Sequencing Market (by Company), 2021
Figure 32: Growth Share Analysis for Global Targeted Sequencing Market (by Application), 2021
Figure 33: Growth Share Analysis for Global Targeted Sequencing Market (by End User), 2021
Figure 34: Evolution of Biological Foundations’ Dominance over Time
Figure 35: Global Targeted Sequencing Market (by Product Type)
Figure 36: Global Targeted Sequencing Market (by Product Type), $Million, 2021 and 2032
Figure 37: Sequencing Services Workflow
Figure 38: Global Targeted Sequencing Market (Services), $Million, 2021-2032
Figure 39: Global Targeted Sequencing Market (Kits/Panels and Assays), $Million, 2021-2032
Figure 40: Global Targeted Sequencing Market (Instruments), $Million, 2021-2032
Figure 41: Global Targeted Sequencing Market (Other Product Types), $Million, 2021-2032
Figure 42: Global Targeted Sequencing Market (by Target Enrichment Method)
Figure 43: Global Targeted Sequencing Market (by Target Enrichment Method), $Million, 2021 and 2032
Figure 44: Workflow of Amplicon Sequencing
Figure 45: Global Targeted Sequencing Market (Amplicon Sequencing), $Million, 2021-2032
Figure 46: Hybridization Capture Workflow
Figure 47: Global Targeted Sequencing Market (Hybridization Capture), $Million, 2021-2032
Figure 48: Global Targeted Sequencing Market (Other Target Enrichment Methods), $Million, 2021-2032
Figure 49: Global Targeted Sequencing Market (by Type of Target Capture)
Figure 50: Global Targeted Sequencing Market (by Type of Target Capture), $Million, 2021 and 2032
Figure 51: Global Targeted Sequencing Market (Targeted DNA Sequencing), $Million, 2021-2032
Figure 52: Targeted Methyl Sequencing Workflow
Figure 53: Targeted RNA Sequencing Workflow
Figure 54: Global Targeted Sequencing Market (Targeted RNA Sequencing), $Million, 2021-2032
Figure 55: Global Targeted Sequencing Market (Other Types of Target Capture), $Million, 2021-2032
Figure 56: Global Targeted Sequencing Market (by Application)
Figure 57: Global Targeted Sequencing Market (by Application), $Million, 2021 and 2032
Figure 58: Global Targeted Sequencing Market (Oncology), $Million, 2021-2032
Figure 59: Global Targeted Sequencing Market (Infectious Diseases), $Million, 2021-2032
Figure 60: Global Targeted Sequencing Market (Cardiovascular Diseases), $Million, 2021-2032

17
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Figure 61: Global Targeted Sequencing Market (Reproductive Health), $Million, 2021-2032
Figure 62: Global Targeted Sequencing Market (Rare Diseases), $Million, 2021-2032
Figure 63: Global Targeted Sequencing Market (Neurological Disorders), $Million, 2021-2032
Figure 64: Global Targeted Sequencing Market (Hereditary Diseases), $Million, 2021-2032
Figure 65: Global Targeted Sequencing Market (Other Applications), $Million, 2021-2032
Figure 66: Global Targeted Sequencing Market (by End User)
Figure 67: Global Targeted Sequencing Market (by End User), $Million, 2021-2032
Figure 68: Global Targeted Sequencing Market (Academic and Research Institutes), $Million, 2021-2032
Figure 69: Global Targeted Sequencing Market (Pharmaceutical and Biotech Companies), $Million, 2021-
2032
Figure 70: Global Targeted Sequencing Market (Diagnostic and Clinical Laboratories), $Million, 2021-2032
Figure 71: Global Targeted Sequencing Market (Other End Users), $Million, 2021-2032
Figure 72: Global Targeted Sequencing Market (by Region)
Figure 73: Global Targeted Sequencing Market (by Region), $Million, 2021-2032
Figure 74: North America Targeted Sequencing Market, $Million, 2021-2032
Figure 75: North America: M-arket Dynamics
Figure 76: North America Targeted Sequencing Market (by Country), $Million, 2021-2032
Figure 77: U.S. Targeted Sequencing Market, $Million, 2021-2032
Figure 78: Canada Targeted Sequencing Market, $Million, 2021-2032
Figure 79: Europe Targeted Sequencing Market, $Million, 2021-2032
Figure 80: Europe: Market Dynamics
Figure 81: Europe Targeted Sequencing Market (by Country), $Million, 2021-2032
Figure 82: Germany Targeted Sequencing Market, $Million, 2021-2032
Figure 83: France Targeted Sequencing Market, $Million, 2021-2032
Figure 84: U.K. Targeted Sequencing Market, $Million, 2021-2032
Figure 85: Italy Targeted Sequencing Market, $Million, 2021-2032
Figure 86: Spain Targeted Sequencing Market, $Million, 2021-2032
Figure 87: Rest-of-Europe Targeted Sequencing Market, $Million, 2021-2032
Figure 88: Asia-Pacific Targeted Sequencing Market, $Million, 2021-2032
Figure 89: Asia-Pacific - Market Dynamics
Figure 90: Asia-Pacific Targeted Sequencing Market (by Country), $Million, 2021-2032
Figure 91: China Targeted Sequencing Market, $Million, 2021-2032
Figure 92: Japan Targeted Sequencing Market, $Million, 2021-2032

18
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Figure 93: India Targeted Sequencing Market, $Million, 2021-2032
Figure 94: Australia Targeted Sequencing Market, $Million, 2021-2032
Figure 95: South Korea Targeted Sequencing Market, $Million, 2021-2032
Figure 96: Rest-of-Asia-Pacific Targeted Sequencing Market, $Million, 2021-2032
Figure 97: Latin America Targeted Sequencing Market, $Million, 2021-2032
Figure 98: Latin America - Market Dynamics
Figure 99: Latin America Targeted Sequencing Market (by Country), $Million, 2021-2032
Figure 100: Brazil Targeted Sequencing Market, $Million, 2021-2032
Figure 101: Mexico Targeted Sequencing Market, $Million, 2021-2032
Figure 102: Rest-of-Latin America Targeted Sequencing Market, $Million, 2021-2032
Figure 103: Rest-of-the-World Targeted Sequencing Market, $Million, 2021-2032
Figure 104: Total Number of Companies Profiled
Figure 105: Global Targeted Sequencing Market: Value Chain
Figure 106: Agilent Technologies, Inc.: Product Portfolio
Figure 107: Agilent Technologies, Inc.: Overall Financials, $Million, 2019-2021
Figure 108: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 109: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 110: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 111: Azenta US, Inc.: Product Portfolio
Figure 112: Azenta US, Inc.: Overall Financials, $Million, 2019-2021
Figure 113: Azenta US, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 114: Azenta US, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 115: Azenta US, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 116: BGI Group: Product Portfolio
Figure 117: CD Genomics: Product Portfolio
Figure 118: Daicel Corporation: Product Portfolio
Figure 119: Daicel Corporation: Overall Financials, $Million, 2020-2022
Figure 120: Daicel Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 121: Daicel Corporation: Revenue (by Region), $Million, 2020-2022
Figure 122: Daicel Corporation: R&D Expenditure, $Million, 2020-2022
Figure 123: Danaher.: Product Portfolio
Figure 124: Danaher.: Overall Financials, $Million, 2019-2021
Figure 125: Danaher.: Revenue (by Segment), $Million, 2019-2021

19
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Figure 126: Danaher.: Revenue (by Region), $Million, 2019-2021
Figure 127: Danaher.: R&D Expenditure, $Million, 2019-2021
Figure 128: F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 129: F. Hoffmann-La Roche Ltd: Overall Financials, 2019-2021
Figure 130: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2019-2021
Figure 131: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2019-2021
Figure 132: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2019-2021
Figure 133: Illumina, Inc.: Product Portfolio
Figure 134: Illumina, Inc.: Overall Financials, $Million, 2019-2021
Figure 135: Illumina, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 136: Illumina, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 137: Illumina, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 138: LGC Limited: Product Portfolio
Figure 139: LGC Limited: Overall Financials, $Million, 2020-2022
Figure 140: LGC Limited: Revenue (by Segment), $Million, 2020-2022
Figure 141: LGC Group: R&D Expenditure, $Million, 2020-2022
Figure 142: PacBio.: Product Portfolio
Figure 143: PacBio.: Overall Financials, $Million, 2019-2021
Figure 144: PacBio.: Revenue (by Segment), $Million, 2019-2021
Figure 145: PacBio.: Revenue (by Region), $Million, 2019-2021
Figure 146: PacBio.: R&D Expenditure, $Million, 2019-2021
Figure 147: PerkinElmer Inc.: Product Portfolio
Figure 148: PerkinElmer Inc.: Overall Financials, $Million, 2019-2021
Figure 149: PerkinElmer Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 150: PerkinElmer Inc.: Revenue (by Region), $Million, 2019-2021
Figure 151: PerkinElmer Inc.: R&D Expenditure, $Million, 2019-2021
Figure 152: Psomagen: Product Portfolio
Figure 153: Psomagen: Overall Financials, $Million, 2019-2021
Figure 154: QIAGEN N.V.: Product Portfolio
Figure 155: QIAGEN N.V.: Overall Financials, $Million, 2019-2021
Figure 156: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 157: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021
Figure 158: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021

20
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Figure 159: Takara Bio Inc.: Product Portfolio
Figure 160: Takara Bio Inc.: Overall Financials, $Million, 2019-2021
Figure 161: Takara Bio Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 162: Takara Bio Inc.: Revenue (by Region), $Million, 2019-2021
Figure 163: Takara Bio Inc.: R&D Expenditure, $Million, 2019-2021
Figure 164: Tecan Trading AG: Product Portfolio
Figure 165: Tecan Trading AG: Overall Financials, $Million, 2019-2021
Figure 166: Tecan Trading AG: Revenue (by Segment), $Million, 2019-2021
Figure 167: Tecan Trading AG: Revenue (by Region), $Million, 2019-2021
Figure 168: Tecan Trading AG: R&D Expenditure, $Million, 2019-2021
Figure 169: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 170: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 171: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 172: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021
Figure 173: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021
Figure 174: Twist Bioscience.: Product Portfolio
Figure 175: Twist Bioscience.: Overall Financials, $Million, 2020-2022
Figure 176: Twist Bioscience.: Revenue (by Segment), $Million, 2020-2022
Figure 177: Twist Bioscience.: Revenue (by Region), $Million, 2020-2022
Figure 178: Twist Biosciences.: R&D Expenditure, $Million, 2020-2022

21
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
List of Tables
Table 1: Likert Scale
Table 2: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Targeted
Sequencing Market
Table 3: Technological Trends in Targeted Sequencing Market
Table 4: Likert Scale
Table 5: Impact Analysis of Market Drivers
Table 6: Impact Analysis of Market Restraints
Table 7: Impact Analysis of Market Opportunities
Table 8: Comparison Between Types of Next-Generation Sequencing Techniques (Comparison)
Table 9: Comparing Targeted Sequencing Methods
Table 10: Advantages and Disadvantages of Liquid Biopsy
Table 11: Whole Genome and Targeted Sequencing Methods using NIPT Data

22
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
BIS Research Offerings:
We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s
digital age. We have the vision to be a leading and preferred knowledge partner for corporates and institutions
worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other
innovative solutions.
Know More Know More
Know More
Know More

23
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth.
This document and its contents are confidential and may not be further distributed, published, or reproduced,
in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS
Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly
through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information
to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce
Information in legal proceedings.
Market reports are based on expectations, estimates, and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to
market fluctuations and business, economic and competitive uncertainties, and contingencies.
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135

24
G
L
O
B
A
L
T
A
R
G
E
T
E
D
S
E
Q
U
E
N
C
I
N
G
M
A
R
K
E
T
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com

TOC - Global Targeted Sequencing Market

Recommended

Recommended

More Related Content

Similar to TOC - Global Targeted Sequencing Market

Similar to TOC - Global Targeted Sequencing Market (20)

More from BIS Research Inc.

More from BIS Research Inc. (20)

Recently uploaded

Recently uploaded (20)

TOC - Global Targeted Sequencing Market